Breast lesion localization method is a pre-surgical procedure where localization devices such as, magnetic tracer, radioisotopes, wires are used to insert into the cancer detected site to localize a non-palpable lesion at the time of surgical excision. This procedure is carried out using surgical guidance systems such as mammography, ultrasound, and Magnetic Resonance Imaging (MRI) depending on the type of lesion and its location.
Breast Lesion Localization Methods Market Dynamics
Drivers
- Increasing number of breast cancer surgeries
- New reimbursement guidelines for breast lesion localization devices placement.
Restraints
- Uncertainty in regulatory approval procedures due to risk associated with breast lesion localization devices
Opportunities
- Technological advancement in breast lesion localization methods such as magnetic tracers
Trend
- Emerging technologies such as electromagnetic reflector
Breast Lesion Localization Methods Market – Comparative Analysis
Increasing Number Of Breast Cancer Cases And Surgeries
Globally, there has been a significant growth in the number of breast cancer cases in women prominently in Europe and Asia-Pacific. This can majorly be attributed to changing lifestyles, increasing use of oral contraceptives, and growing number of women undergoing cosmetic surgeries like breast enhancement. Breast cancer is considered to be the second most common type of cancer globally, and is the most common cause of death among women. Among the total population diagnosed with breast cancer, around 25%-27% population undergoes surgeries per year. The number of breast cancer surgeries with a localization process was 1.95 million in 2013 and this figure is expected to increase by 10.9% to reach 4.37 million procedures by 2020. The growing number of breast cancer surgeries, coupled with the growing need for new, technically advanced, and less expensive surgical processes and breast lesion localization methods. This leads to increase breast lesion localization methods market in the coming years
According to the replacement trend studied among all geographic regions, wire localization is long established technique of preoperative localization of breast lesion and most of the respondent using this and willing to continue with the same. But nearly about 40% of the healthcare providers are willing to shift towards technologically advanced options such as RSL, magnetic tracers etc.
Some of the key players in breast lesion localization method market are C.R. Bard (US), Ranfac Corporation ((US), Invivo Corporation (US), SOMATEX Medical Technologies GmbH (Germany), Argon Medical Devices (US), SurgicEye GmbH (Germany), GE Healthcare (UK), Intra-Medical Imaging LLC (US), IsoAid, LLC (US), NuclearLab S.R.L. (Argentina), Cianna Medical (US), Endomagnetics Ltd. (UK), and Cook Medical (US). The major strategy adopted by companies to strengthen their position is new product development and seeking patents, licenses for new and technologically advanced localization methods such as radioactive seed localization, magnetic tracers.
Read More about Breast Lesion Localization Methods Market:
